SCHEMBL13245289

SCHEMBL13245289

CC(=O)Oc1cc(C)cc(C)c1C(C)(C)CC(=O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 4/20 0.38
HSD17B10 Q99714 2/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
ELANE P08246 2/20 0.36
ACHE P22303 1/20 0.34
VDR P11473 1/20 0.33
HTT P42858 1/20 0.33
GLA P06280 2/20 0.32
GAA P10253 2/20 0.32
GFER P55789 1/20 0.32
POLB P06746 1/20 0.32
CYP2C9 P11712 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
MAPT P10636 1/20 0.32
ALPG P10696 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21662664 0.88 ELANE (0.38) ALDH1A1KDM4EHSD17B10LMNAELANE
SCHEMBL2515529 0.87 ELANE (0.37) ALDH1A1KDM4EHSD17B10TSHRELANE
SCHEMBL29450106 0.87 ELANE (0.37) ALDH1A1KDM4EHSD17B10TSHRELANE
Hydrochloric Acid SCHEMBL29259039 0.86 ELANE (0.36) ALDH1A1KDM4ETSHRELANEACHE
SCHEMBL21342598 0.86 ELANE (0.36) ALDH1A1KDM4EHSD17B10LMNAELANE
SCHEMBL23832314 0.86 ELANE (0.36) ALDH1A1KDM4EHSD17B10LMNAELANE
SCHEMBL18121368 0.86 ELANE (0.36) ALDH1A1KDM4EHSD17B10LMNATSHR
SCHEMBL30152011 0.86 ELANE (0.36) ALDH1A1KDM4EHSD17B10LMNAELANE
SCHEMBL21662665 0.85 ELANE (0.35) ALDH1A1KDM4EHSD17B10LMNATSHR
SCHEMBL18121459 0.84 ELANE (0.38) ALDH1A1KDM4EHSD17B10TSHRELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200040015-A1 PRODRUG COMPOSITIONS THE JOHNS HOPKINS UNIVERSITY 2020-02-06 US disclosed
US-20100173851-A1 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE VERTEX PHARMACEUTICALS INCORPORATED 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200040015-A1 PRODRUG COMPOSITIONS ABCB1, TYMP, PNP ALDH1A1 303/4885KDM4E 2649/4885HSD17B10 986/4885
US-20100173851-A1 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE SERPINB1, PRSS1, SPINT2 ALDH1A1 2015/4885KDM4E 1073/4885HSD17B10 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.